• OPEN AN ACCOUNT
A+| A| A-|
Indian Indices
Sensex
75,415.35 231.99
( 0.31%)
Global Indices
Nasdaq
50,600.73 294.06
(0.58%)
Dow Jones
7,493.73 27.01
(0.36%)
Hang Seng
63,328.42 1,644.28
(2.67%)
Nikkei 225
10,474.02 30.55
(0.29%)
Forex
USD-INR
96.29 -0.42
(-0.43%)
EUR-INR
111.82 -0.44
(-0.39%)
GBP-INR
129.28 -0.40
(-0.31%)
JPY-INR
0.61 0.00
(-0.48%)

EQUITY - MARKET SCREENER

Ajanta Pharma Ltd
Industry :  Pharmaceuticals - Indian - Formulations
BSE Code
ISIN Demat
Book Value()
532331
INE031B01049
338.0498657
NSE Symbol
P/E(TTM)
Mar.Cap( Cr.)
AJANTPHARM
40.99
38804.38
EPS(TTM)
Face Value()
Div & Yield %
75.78
2
0
 

As on: May 22, 2026 12:00 AM

Last Price() Net Change (%) Volume (Nos) P / E
3,105.95 -42.15 1687 40.99
Stock Price Details
Open Price() 3,148.10
Best Buy () 0
Best Sell () 0
Buy Quantity (Nos) 0
Sell Quantity (Nos) 0
Today's High () 3,164.35
Today's Low () 3,098.60
52-Week High () 3314.8
152-Week Low () 2335
CHART
  • |
  • |
  • |
  • |
Market Statistics
Div & Yield % 0.00
Eps 75.78
Book Value 338.0498657
Market Cap (.Cr) 38,804.38
Face Value 2
Market Lot 1
AGM Date Jul
Book Closure Date
ISIN No. INE031B01049


News
Ajanta Pharma Ltd spurts 1.08%, rises for third straight session
Ajanta Pharma rises after Q4 PAT climbs 18% YoY
Nifty trades above 24,150 mark; auto shares rev up for 3rd day
Volumes soar at Tejas Networks Ltd counter
Ajanta Pharma consolidated net profit rises 18.40% in the March 2026 quarter
Ajanta Pharma's Paithan unit concludes USFDA inspection
Ajanta Pharma gets USFDA Form 483 with five observations at Paithan plant
Ajanta Pharma to declare Quarterly Results
Ajanta Pharma Ltd spurts 3.48%
Ajanta Pharma Ltd soars 0.41%, up for fifth straight session
More
Corporate Details
Incoporation Year   : 1979
Chairman : Mannalal B Agrawal
Bussiness Group : Indian Private
Registered Office
Ajanta Pharma Ltd
Ajanta House,
Charkop Kandivli (W),
Mumbai,
Maharashtra-400067
Cement House,
121 Maharshi Karve Road,
Mumbai,
Maharashtra-400020
Phone:91-22-66061000/1204/1203
Fax:91-22-66061200/1300
Fax:91-22-66317458
E-Mail : info@ajantapharma.com; investorgrievance@ajantapha
URL : http://www.ajantapharma.com


Exchange Information
Bombay Stock Exchange National Stock Exchange Other Listed Exchanges
  • BSE 500
  • BSE HC
  • BSE Midcap
  • CNX 500
  • CNX Pharma
  • BSE
  • Kolkata
  • Chennai
  • Ahmedabad
  • Delhi
  • Kochi